Effect of High (200 μg/kg per Minute) Adenosine Dose Infusion on Fractional Flow Reserve Variability.
Autor: | Alexopoulos D; Department of Cardiology, Patras University Hospital, Rion Patras, Greece dalex@med.uoa.gr., Xanthopoulou I; Department of Cardiology, Patras University Hospital, Rion Patras, Greece., Tsigkas G; Department of Cardiology, Patras University Hospital, Rion Patras, Greece., Koutsogiannis N; Department of Cardiology, Patras University Hospital, Rion Patras, Greece., Salata P; Department of Cardiology, Patras University Hospital, Rion Patras, Greece., Armylagos S; Department of Cardiology, Patras University Hospital, Rion Patras, Greece., Moulias A; Department of Cardiology, Patras University Hospital, Rion Patras, Greece., Davlouros P; Department of Cardiology, Patras University Hospital, Rion Patras, Greece. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of the American Heart Association [J Am Heart Assoc] 2016 Nov 10; Vol. 5 (11). Date of Electronic Publication: 2016 Nov 10. |
DOI: | 10.1161/JAHA.116.004323 |
Abstrakt: | Background: Variations in distal coronary pressure (Pd)/aortic pressure (Pa) ratio during steady-state hyperemia with standard (140 μg/kg per minute) adenosine dose may hamper accurate fractional flow reserve assessment. This study investigated to what extent an increased adenosine dose can overcome Pd/Pa variation. Methods and Results: In a prospective, single-arm study, out of 95 prospectively screened patients, 38 (40.0%) exhibited significant (≥0.05 difference of max Pd/Pa minus min Pd/Pa) variations in Pd/Pa from 15 s post Pd/Pa dip and until the end of a 3-minute adenosine (140 μg/kg per minute) infusion. Thirty patients agreed to participate in a post 5-minute repeat fractional flow reserve assessment using 200 μg/kg per minute 3-minute adenosine infusion. The study's co-primary end point of Pd/Pa coefficient of dispersion was lower for the high versus standard adenosine dose: 1.31 (1.13-2.72) versus 2.76 (2.38-5.60), P=0.002. The study's co-primary end point of ΔPd/Pa was also lower for the high versus standard adenosine dose: 0.065 (0.038-0.10) versus 0.08 (0.06-0.11), P=0.002. This difference was mainly driven by the lowering effect of the high adenosine dose on the maximum Pd/Pa compared to the standard dose: 0.84 (0.81-0.93) versus 0.90 (0.83-0.95), P=0.007, while minimum Pd/Pa remained unaffected. High adenosine dose was adequately tolerated by all patients, without requiring infusion discontinuation in any case. Conclusions: Pd/Pa variability is frequently observed during standard adenosine infusion and is significantly decreased following a high (200 μg/kg per minute) adenosine dose. This is achieved without a significant difference in the minimum Pd/Pa. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02350439. (© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.) |
Databáze: | MEDLINE |
Externí odkaz: |